Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease

Robert A. Rosenheck; Douglas L. Leslie; Jody L. Sindelar; Edward A. Miller; Peter N. Tariot; Karen S. Dagerman; Sonia M. Davis; Barry D. Lebowitz; Peter Rabins; John K. Hsiao; Jeffery A. Lieberman; Lon S. Schneider

doi:10.1001/archpsyc.64.11.1259

Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease

Robert A. Rosenheck
, Douglas L. Leslie
, Jody L. Sindelar
, Edward A. Miller
, Peter N. Tariot
, Karen S. Dagerman
, Sonia M. Davis
, Barry D. Lebowitz
, Peter Rabins
, John K. Hsiao
, Jeffery A. Lieberman
, Lon S. Schneider

Gerontology

Department of Veterans Affairs
Yale University
University of Southern California
University of Arizona
University of North Carolina at Chapel Hill
University of California at San Diego
Johns Hopkins University
National Institutes of Health
Columbia University

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1259-1268
Number of pages	10
Journal	Archives of General Psychiatry
Volume	64
Issue number	11
DOIs	https://doi.org/10.1001/archpsyc.64.11.1259
State	Published - Nov 2007

ASJC Scopus Subject Areas

Arts and Humanities (miscellaneous)
Psychiatry and Mental health

Access to Document

10.1001/archpsyc.64.11.1259

Cite this

Rosenheck, R. A., Leslie, D. L., Sindelar, J. L., Miller, E. A., Tariot, P. N., Dagerman, K. S., Davis, S. M., Lebowitz, B. D., Rabins, P., Hsiao, J. K., Lieberman, J. A., & Schneider, L. S. (2007). Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease. Archives of General Psychiatry, 64(11), 1259-1268. https://doi.org/10.1001/archpsyc.64.11.1259

Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease. / Rosenheck, Robert A.; Leslie, Douglas L.; Sindelar, Jody L. et al.
In: Archives of General Psychiatry, Vol. 64, No. 11, 11.2007, p. 1259-1268.

Research output: Contribution to journal › Article › peer-review

Rosenheck, RA, Leslie, DL, Sindelar, JL, Miller, EA, Tariot, PN, Dagerman, KS, Davis, SM, Lebowitz, BD, Rabins, P, Hsiao, JK, Lieberman, JA & Schneider, LS 2007, 'Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease', Archives of General Psychiatry, vol. 64, no. 11, pp. 1259-1268. https://doi.org/10.1001/archpsyc.64.11.1259

@article{6549530062a148f0b05d734bc06b575b,

title = "Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease",

author = "Rosenheck, \{Robert A.\} and Leslie, \{Douglas L.\} and Sindelar, \{Jody L.\} and Miller, \{Edward A.\} and Tariot, \{Peter N.\} and Dagerman, \{Karen S.\} and Davis, \{Sonia M.\} and Lebowitz, \{Barry D.\} and Peter Rabins and Hsiao, \{John K.\} and Lieberman, \{Jeffery A.\} and Schneider, \{Lon S.\}",

year = "2007",

month = nov,

doi = "10.1001/archpsyc.64.11.1259",

language = "English",

volume = "64",

pages = "1259--1268",

journal = "Archives of General Psychiatry",

issn = "0003-990X",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease

AU - Rosenheck, Robert A.

AU - Leslie, Douglas L.

AU - Sindelar, Jody L.

AU - Miller, Edward A.

AU - Tariot, Peter N.

AU - Dagerman, Karen S.

AU - Davis, Sonia M.

AU - Lebowitz, Barry D.

AU - Rabins, Peter

AU - Hsiao, John K.

AU - Lieberman, Jeffery A.

AU - Schneider, Lon S.

PY - 2007/11

Y1 - 2007/11

UR - https://www.scopus.com/pages/publications/35948979240

UR - https://www.scopus.com/pages/publications/35948979240#tab=citedBy

U2 - 10.1001/archpsyc.64.11.1259

DO - 10.1001/archpsyc.64.11.1259

M3 - Article

C2 - 17984395

AN - SCOPUS:35948979240

SN - 0003-990X

VL - 64

SP - 1259

EP - 1268

JO - Archives of General Psychiatry

JF - Archives of General Psychiatry

IS - 11

ER -

Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in alzheimer disease

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this